Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Nov 14, 2025, after the close
10-Q filed Nov 14, 2025, 45 days after period end · 0001493152-25-023539
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$3.71M | -$2.67M | -$2.39M | -$2.32M |
| EPS Diluted | -$0.27 | -$0.20 | -$0.19 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
1.1% from the close of Nov 14, 2025 to the close of Nov 17, 2025, the first after the release.